Daily News Podcast

Automated office BP readings

Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab are stopped.

Conference Coverage

Combo emerges as bridge to transplant in rel/ref PTCL

LA JOLLA, CALIF. – Researchers plan to expand the duvelisib plus romidepsin arm to better understand the occurrence of transaminitis and assess...

Conference Coverage

Applying ECHELON-2 results to clinical practice

LA JOLLA, CALIF. – At the annual T-cell Lymphoma Forum, physicians discussed how the ECHELON-2 trial may affect clinical practice.